Preservision Valeant announced that PreserVision AREDS 2 Formula + Multivitamin is now available for patients with moderate to advanced age-related macular degeneration. The new 2-in-1 product is the ...

BRIDGEWATER, N.J., Oct. 21, 2019 /PRNewswire/ -- Bausch + Lomb, a leading global eye health company and wholly owned subsidiary of Bausch Health Companies Inc. (NYSE/TXS: BHC), today announced the U.S ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Bausch + Lomb has launched a new formulation of ...

MPR, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient outcomes.

“For my patients with moderate to advanced Age-related Macular Degeneration (AMD), a leading cause of vision loss in Americans ages 50 and older, I typically recommend a plan that includes a healthy ...

Valeant Pharmaceuticals International, Inc. announced that its wholly owned subsidiary, Bausch + Lomb, a leading global eye health company, launched new PreserVision AREDS 2 Formula + Multivitamin.

Bausch + Lomb debuts PreserVision AREDS 2 Formula soft gels plus CoQ10 The soft gels contain the nutrient formula recommended by the National Eye Institute to help reduce the risk of moderate to ...

Enhanced Vitamin Includes the Same Clinically Proven AREDS 2 Formula with New Lutein and Zeaxanthin Formulation that Offers Superior Absorption ...